Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective

Review

Closing remarks

Ravinder N Maini

Arthritis Res Ther 2004, 6(Suppl 2):S44  doi:10.1186/ar998

Accesses  

  • Last 30 days: 11 accesses
  • Last 365 days: 130 accesses
  • All time: 1552 accesses